These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25231439)

  • 1. Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone.
    Verbeke SL; de Jong D; Bertoni F; Sciot R; Antonescu CR; Szuhai K; Bovée JV
    Genes Chromosomes Cancer; 2015 Feb; 54(2):72-81. PubMed ID: 25231439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.
    Tarkkanen M; Larramendy ML; Böhling T; Serra M; Hattinger CM; Kivioja A; Elomaa I; Picci P; Knuutila S
    Eur J Cancer; 2006 May; 42(8):1172-80. PubMed ID: 16630715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
    Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
    BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
    Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
    J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
    Manner J; Radlwimmer B; Hohenberger P; Mössinger K; Küffer S; Sauer C; Belharazem D; Zettl A; Coindre JM; Hallermann C; Hartmann JT; Katenkamp D; Katenkamp K; Schöffski P; Sciot R; Wozniak A; Lichter P; Marx A; Ströbel P
    Am J Pathol; 2010 Jan; 176(1):34-9. PubMed ID: 20008140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis of a primary bone angiosarcoma.
    Dunlap JB; Magenis RE; Davis C; Himoe E; Mansoor A
    Cancer Genet Cytogenet; 2009 Oct; 194(1):1-3. PubMed ID: 19737647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent upregulation of MYC in plasma cell leukemia.
    Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
    Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
    Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
    Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array.
    Martínez-Ramírez A; Urioste M; Melchor L; Blesa D; Valle L; de Andrés SA; Kok K; Calasanz MJ; Cigudosa JC; Benítez J
    Genes Chromosomes Cancer; 2005 Mar; 42(3):287-98. PubMed ID: 15611930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridization in four angiosarcomas of the female breast.
    Baumhoer D; Gunawan B; Becker H; Füzesi L
    Gynecol Oncol; 2005 May; 97(2):348-52. PubMed ID: 15863129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
    Italiano A; Thomas R; Breen M; Zhang L; Crago AM; Singer S; Khanin R; Maki RG; Mihailovic A; Hafner M; Tuschl T; Antonescu CR
    Genes Chromosomes Cancer; 2012 Jun; 51(6):569-78. PubMed ID: 22383169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.
    Fan CS; Wong N; Leung SF; To KF; Lo KW; Lee SW; Mok TS; Johnson PJ; Huang DP
    Hum Pathol; 2000 Feb; 31(2):169-78. PubMed ID: 10685630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.